News

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
Here's what to know about the FDA's COVID-19 vaccine changes
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
What the New COVID-19 Vaccine Guidance Means For You
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...
FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
Healio1h
FDA committee recommends formula for fall COVID-19 vaccines
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
BioSpace8h
FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...